A coalition of cannabis businesses, represented by a prominent law firm, has initiated a long-awaited legal action against the U.S. attorney general. Their goal is to prevent the federal government from enforcing cannabis prohibition in states where it’s been legalized. These companies argue that maintaining prohibition in state-regulated markets is unconstitutional, endangering public safety and preventing licensed cannabis businesses from accessing essential financial services and tax benefits available to other industries.

The lawsuit was formally filed in the U.S. District Court for the District of Massachusetts, Western Division. It was brought forward by Verano Holdings Corp., a multi-state operator, alongside Massachusetts-based cannabis companies, Canna Provisions and Wiseacre Farm, and Treevit CEO Gyasi Sellers. Notably, Ascend Wellness Holdings, TerrAscend, Green Thumb Industries, Eminence Capital, and Poseidon Investment Management are “foundational supporters” of this legal challenge.

The plaintiffs are being represented by the law firms Boies Schiller Flexner and Lesser, Newman, Aleo & Nasser LLP. David Boies, the chairman of the former firm, has represented clients such as the Justice Department, former Vice President Al Gore, and parties involved in the case that led to the overturning of California’s same-sex marriage ban.

The lawsuit contends that while Congress originally implemented a cannabis ban through the Controlled Substances Act (CSA) to curb interstate commerce, which ostensibly gave the federal government a legal basis to enforce prohibition at the state level, lawmakers and the executive branch have since abandoned that mission as more states have embraced cannabis legalization.

The complaint argues, “Despite these changes, the federal criminal prohibition on intrastate cannabis remains in place, an unjustified vestige of a long-abandoned policy. This unjustified intrusion of federal power harms Plaintiffs, threatens the communities they serve, and lacks any rational purpose.”

The lawsuit highlights that even though the federal government has adopted a largely hands-off approach to cannabis in recent years, state-licensed cannabis businesses continue to face unique financial challenges. These include a lack of access to banking services, credit cards, and federal tax deductions, specifically under IRS code 280E. Because of these limitations, state-regulated cannabis businesses are forced to rely heavily on cash, leading to significant public safety risks and making them targets for robberies.

The lawsuit further argues that the existing federal ban on cannabis, as outlined in the CSA, constitutes an unconstitutional encroachment on state sovereignty. It contends that Congress has the authority to regulate cannabis in interstate commerce but lacks the constitutional power to regulate it when it’s grown, transported, and distributed intrastate.

The lawsuit delves into the history of cannabis laws in the United States, highlighting that prohibition is a relatively recent policy shift following over a century of legal use and cultivation to some extent. It also points out that the original justification for banning cannabis under the CSA, aimed at preventing interstate commerce, no longer applies.

The legal action is taking place as the Drug Enforcement Administration (DEA) reviews cannabis scheduling following a recommendation by the U.S. Department of Health and Human Services (HHS) to move cannabis from Schedule I to Schedule III under the CSA. While rescheduling could address certain tax-related issues for the industry, it wouldn’t fully legalize cannabis or permit intrastate commerce.

This lawsuit is significant for the cannabis industry, particularly for smaller businesses that have suffered from the unequal treatment and financial burdens caused by the federal government’s policies. The plaintiffs hope to set a new precedent that will allow states to regulate and support cannabis businesses under their own guidelines. The legal battle is expected to proceed, with the possibility of reaching the Supreme Court in the near future, potentially leading to a permanent change in how the federal government handles cannabis.

Source: Marijuana Moment

EXPLORE MORE NEWS

Major Corporations Investing in Cannabis

As cannabis legalization continues to spread across the country, major corporations are increasingly taking notice and investing in the industry. In April of 2023, a major beverage company announced a $100 million investment in a cannabis-infused drink startup, signaling the growing trend of large corporations entering the cannabis space.

Despite recent challenges, the California Cannabis GDP could still support a small island nation.

California’s marijuana industry continues to dominate as the world’s largest cannabis market, despite facing financial and tax challenges. According to the recently published MJBiz Factbook, the state is estimated to generate nearly $5.9 billion in legal recreational and medical marijuana sales in 2023. To put this into perspective, the revenue from marijuana sales in California could support the economy of a small island nation.

U.S. Cannabis Sales Could Total $71B in 2030 Without Federal Legalization

The recently released 2023 U.S. Cannabis Report by New Frontier Data has shed light on the remarkable growth potential of the cannabis industry in the United States. With state-level legalization gaining momentum and the absence of federal policy reform, the report predicts a substantial increase in annual cannabis sales over the next seven years.

Unveiling the Midwest: Exploring Cannabis Legalization and Consumer Behavior

Can it find acceptance in Peoria? This quintessential American question examines the likelihood of a new trend, behavior, or occurrence gaining widespread approval. The term “Peoria” refers to the city in Illinois and embodies the notion that if a concept gains traction in the Midwest, it attains a mainstream status. When the wave of cannabis legalization emerged in 2012, it primarily took root in predictable locales – the coasts. Early victories for legalization in states like Colorado, Oregon, Washington, and Maine were not unexpected, given their reputation for a blend of progressive and Libertarian-leaning politics. However, the real question lingered: When would this movement extend to the Heartland? The answer arrived in 2018, when Michigan became the first Midwestern state to endorse adult-use legalization. With progressive pockets such as Ann Arbor and the presence of an urban hub like Detroit, Michigan might have been perceived as an outlier. Subsequently, Illinois followed suit in 2020, and to the astonishment of many, Missouri in 2022. The latest addition to this Midwestern lineup is Minnesota, with its recent introduction of an adult-use cannabis initiative. Ohio aims to place a similar measure on the ballot in 2024. As for Iowa, Indiana, and Wisconsin? The prospect appears remote.

Newsletter